Myriad Genetics Inc.
Organization details
- Legal name
- Myriad Genetics Inc.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2835 — In Vitro & In Vivo Diagnostic Substances
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Salt Lake City
- Headquarters state / province
- Utah
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- MYGN
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0000899923
- EIN
- 87-0494517
- Wikidata ID
- Q3331496
Board of directors
-
Colleen F. Reitan · DirectorSince 2023
- Since 2023
-
Daniel Skovronsky · DirectorSince 2023
-
Heinrich Dreismann · DirectorSince 2023
-
Lee Nisley Newcomer · DirectorSince 2023
-
Mark Steven Davis · DirectorSince 2024
-
Paul Bisaro · DirectorSince 2023
-
Paul J. Diaz · Director · President and CEOSince 2023
-
Rashmi Kumar · DirectorSince 2023
-
S. Louise Phanstiel · DirectorSince 2023
-
Samraat S. Raha · Director · President and CEOSince 2025
Chief executives
Director election results
Annual meeting of June 4, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
96.7%
-
98.6%
-
99.0%
Board connections
9 of this board's directors also sit on 14 other boards. 11 are in the same sector.
-
Alnylam Pharmaceuticals Inc. Same sectorvia Colleen F. Reitan
-
Butterfly Network Inc. Same sectorvia S. Louise Phanstiel
- via Paul J. Diaz
-
Coherus Oncology Inc. Same sectorvia Lee Nisley Newcomer
-
DaVita Inc. Same sectorvia Paul J. Diaz
- via Daniel Skovronsky
-
Kyverna Therapeutics Inc. Same sectorvia Daniel K. Spiegelman
-
Maze Therapeutics Inc. Same sectorvia Daniel K. Spiegelman
-
Merck & Company Inc. Same sectorvia Paul J. Diaz
-
Quantum Cyber N.V. Same sectorvia Heinrich Dreismann
-
Spruce Biosciences Inc. Same sectorvia Daniel K. Spiegelman
- via Mark Steven Davis
-
Zoetis Inc. Same sectorvia Paul Bisaro
-
vTv Therapeutics Inc. Same sectorvia Daniel K. Spiegelman
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $722,223
- 5 purchases by 3 insiders
- Sold, last 12 months
- $66,900
- 1 sale by 1 insider
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 1, 2026 | Fox Jennifer Lynne Officer (Chief Legal & Corp Strategy) | Grant or award | +39,370 | — | — |
| Sep 21, 2026 | Wheeler Benjamin Richard Officer (Chief Financial Officer) | Shares withheld for tax | −2,555 | $4.01 | $10,246 |
| Sep 16, 2026 | Sikri Vishal Officer (EVP, Commercial) | Grant or award | +257,731 | — | — |
| Sep 3, 2026 | Fox Jennifer Lynne Officer (Chief Legal Officer) | Shares withheld for tax | −4,398 | $3.23 | $14,206 |
| Aug 16, 2026 | Wheeler Benjamin Richard Officer (Chief Financial Officer) | Shares withheld for tax | −8,761 | $3.03 | $26,546 |
| Jun 11, 2026 | Samraat S. Raha Director, Officer (President and CEO) | Grant or award | +3,542 | $3.94 | $13,955 |
| Jun 11, 2026 | Donnelly Brian J Officer (Chief Commerical Officer) | Grant or award | +5,000 | $3.94 | $19,700 |
| Jun 8, 2026 | Rashmi Kumar Director | Open-market sale | −15,000 | $4.46 | $66,900 |
| Jun 4, 2026 | Daniel Skovronsky Director | Grant or award | +59,701 | — | — |
| Jun 4, 2026 | Lee Nisley Newcomer Director | Grant or award | +59,701 | — | — |
| Jun 4, 2026 | Mark Steven Davis Director | Grant or award | +59,701 | — | — |
| Jun 4, 2026 | S. Louise Phanstiel Director | Grant or award | +59,701 | — | — |
| Jun 4, 2026 | Heinrich Dreismann Director | Grant or award | +59,701 | — | — |
| Jun 4, 2026 | Colleen F. Reitan Director | Grant or award | +59,701 | — | — |
| Jun 4, 2026 | Paul Bisaro Director | Grant or award | +59,701 | — | — |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Myriad Genetics Inc.
Who is the CEO of Myriad Genetics Inc.?
Paul J. Diaz is Myriad Genetics Inc.'s President and CEO.
How many directors are on Myriad Genetics Inc.'s board?
Myriad Genetics Inc.'s board has 11 directors: Colleen F. Reitan, Daniel K. Spiegelman, Daniel Skovronsky, Heinrich Dreismann, Lee Nisley Newcomer, Mark Steven Davis, Paul Bisaro, Paul J. Diaz, Rashmi Kumar, S. Louise Phanstiel and 1 other.
Are Myriad Genetics Inc. insiders buying or selling shares?
Over the last 12 months, Myriad Genetics Inc. insiders bought $722,223 of shares in 5 purchases and sold $66,900 of shares in 1 sale on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="myriad-genetics-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.